Skip to main content
Tech.euFundingExplorerBeta

Nanolive

Explore a living cell in 3D without damaging it

Nanolive has raised €23M across 4 funding rounds from 3 investors, most recently a Series C round in Sep 2022. Based in Ecublens, Switzerland; founded 2013; active in Healthtech. Data as of 28 Oct 2026.

Ecublens, SwitzerlandFounded 2013nanolive.ch ↗
Total raised
€23M
€23,376,641
Funding rounds
4
Investors
3
distinct backers
Active since
2014-04
latest 2022-09

Funding by year

EUR raised per year
Nanolive — funding by year — interactive chart.
Data table
Nanolive — funding by year
2014€2.5M
2016€500k
2022€20M

Signals

High confidence
Raise-next likelihood8
base rate 50% for Series C
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2022-09-20Series C€2.2MInnoviva,Taiwania CapitalView deal →
2022-04-04Series C€18MSwisscom Ventures,Taiwania CapitalView deal →
2016-10-01Early VC€500kSwisscom VenturesView deal →
2014-04-01Early VC€2.5M—View deal →

Similar companies

same sector or country

Global coverage: FundingData